---
title: "Taysha Gene Therapies (TSHA.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TSHA.US/norm.md"
symbol: "TSHA.US"
name: "Taysha Gene Therapies"
parent: "https://longbridge.com/en/quote/TSHA.US.md"
datetime: "2026-05-21T18:21:07.893Z"
locales:
  - [en](https://longbridge.com/en/quote/TSHA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TSHA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TSHA.US/norm.md)
---

# Taysha Gene Therapies (TSHA.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1157 | -0.0779 | -0.0926 | -0.0902 | -0.0799 |
| ROE | -73.94% | -47.82% | -55.99% | -70.79% | -136.06% |
| Revenue | - | 5.49M | - | 1.99M | 2.30M |
| Net income | -42.41M | -27.85M | -32.73M | -26.88M | -21.53M |
| Operating income | -43.49M | -28.30M | -34.02M | -26.75M | -21.42M |
| Gross margin | - | 100.00% | - | 100.00% | 100.00% |
| Net margin | - | -507.77% | - | -1353.58% | -935.23% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 300.35M | 343.32M | 316.55M | 333.33M | 138.36M |
| Leverage | 1.42 | 1.39 | 1.45 | 1.34 | 2.51 |
| BVPS | 0.7378 | 0.8663 | 0.7995 | 0.9120 | 0.2685 |
| Turnover | 0.0341 | 0.0388 | 0.0254 | 0.0303 | 0.0496 |
| Cash & STI | 276.58M | 319.77M | 297.34M | 312.76M | 116.59M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 15.61M | 16.18M | 14.27M | 14.73M | 15.31M |
| Net debt | -208.03M | -249.62M | -228.26M | -253.00M | -54.96M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -40.88M | -26.72M | -24.17M | -20.18M | -22.02M |
| Investing CF | -3.02M | -247000.00 | -48000.00 | 62000.00 | -371000.00 |
| Financing CF | 711000.00 | 49.56M | 8.80M | 216.29M | -52000.00 |
| Free CF | -31.57M | -18.66M | -13.55M | -9.78M | -14.81M |
| OCF coverage | -170325.00% | -10688.80% | -59.35% | -1009100.00% | -5825.40% |
| Repaid & issued | - | 0.0000 | 49.85M | - | - |
| CapEx | -24000.00 | -250000.00 | -108000.00 | -2000.00 | -378000.00 |